Menu
Back to Journals » Breast Cancer: Targets and Therapy » Volume 9
Review
Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,363 | Dovepress* | 8,165+ | 1,291 | 9,456 | |
| PubMed Central* | 1,198 | 612 | 1,810 | ||
| Totals | 9,363 | 1,903 | 11,266 | ||
| *Since 6 December 2017 | |||||
View citations on PubMed Central and Google Scholar